320 related articles for article (PubMed ID: 31703406)
1. Inflammation and Coronary Microvascular Dysfunction in Autoimmune Rheumatic Diseases.
Zanatta E; Colombo C; D'Amico G; d'Humières T; Dal Lin C; Tona F
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31703406
[TBL] [Abstract][Full Text] [Related]
2. Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases.
Faccini A; Kaski JC; Camici PG
Eur Heart J; 2016 Jun; 37(23):1799-806. PubMed ID: 26912605
[TBL] [Abstract][Full Text] [Related]
3. The pathogenic role of coronary microvascular dysfunction in the setting of other cardiac or systemic conditions.
Konst RE; Guzik TJ; Kaski JC; Maas AHEM; Elias-Smale SE
Cardiovasc Res; 2020 Mar; 116(4):817-828. PubMed ID: 31977015
[TBL] [Abstract][Full Text] [Related]
4. Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality.
Nussinovitch U; Shoenfeld Y
Autoimmun Rev; 2011 Mar; 10(5):259-66. PubMed ID: 20863903
[TBL] [Abstract][Full Text] [Related]
5. Chronic Inflammatory Disease Is an Independent Risk Factor for Coronary Flow Velocity Reserve Impairment Unrelated to the Processes of Coronary Artery Calcium Deposition.
Kakuta K; Dohi K; Sato Y; Yamanaka T; Kawamura M; Ogura T; Nakamori S; Fujimoto N; Fujii E; Yamada N; Ito M
J Am Soc Echocardiogr; 2016 Feb; 29(2):173-80. PubMed ID: 26443046
[TBL] [Abstract][Full Text] [Related]
6. Coronary microvascular disease: The "Meeting Point" of Cardiology, Rheumatology and Endocrinology.
Markousis-Mavrogenis G; Bacopoulou F; Mavragani C; Voulgari P; Kolovou G; Kitas GD; Chrousos GP; Mavrogeni SI
Eur J Clin Invest; 2022 May; 52(5):e13737. PubMed ID: 34939183
[TBL] [Abstract][Full Text] [Related]
7. Ocular microvascular damage in autoimmune rheumatic diseases: The pathophysiological role of the immune system.
Hysa E; Cutolo CA; Gotelli E; Paolino S; Cimmino MA; Pacini G; Pizzorni C; Sulli A; Smith V; Cutolo M
Autoimmun Rev; 2021 May; 20(5):102796. PubMed ID: 33722750
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular disease in autoimmune rheumatic diseases.
Hollan I; Meroni PL; Ahearn JM; Cohen Tervaert JW; Curran S; Goodyear CS; Hestad KA; Kahaleh B; Riggio M; Shields K; Wasko MC
Autoimmun Rev; 2013 Aug; 12(10):1004-15. PubMed ID: 23541482
[TBL] [Abstract][Full Text] [Related]
9. Regulatory B cells: New players in inflammatory and autoimmune rheumatic diseases.
Sakkas LI; Daoussis D; Mavropoulos A; Liossis SN; Bogdanos DP
Semin Arthritis Rheum; 2019 Jun; 48(6):1133-1141. PubMed ID: 30409417
[TBL] [Abstract][Full Text] [Related]
10. What rheumatologists should know about orofacial manifestations of autoimmune rheumatic diseases.
Abrão AL; Santana CM; Bezerra AC; Amorim RF; Silva MB; Mota LM; Falcão DP
Rev Bras Reumatol Engl Ed; 2016; 56(5):441-450. PubMed ID: 27692394
[TBL] [Abstract][Full Text] [Related]
11. Assessing Coronary Microvascular Dysfunction in Ischaemic Heart Disease: Little Things Can Make a Big Difference.
Xu J; Lo S; Juergens CP; Leung DY
Heart Lung Circ; 2020 Jan; 29(1):118-127. PubMed ID: 31255478
[TBL] [Abstract][Full Text] [Related]
12. Endothelial dysfunction in rheumatic autoimmune diseases.
Murdaca G; Colombo BM; Cagnati P; Gulli R; Spanò F; Puppo F
Atherosclerosis; 2012 Oct; 224(2):309-17. PubMed ID: 22673743
[TBL] [Abstract][Full Text] [Related]
13. A comparison of health-related quality of life (HRQoL) across four systemic autoimmune rheumatic diseases (SARDs).
Greenfield J; Hudson M; Vinet E; Fortin PR; Bykerk V; Pineau CA; Wang M; Bernatsky S; Baron M;
PLoS One; 2017; 12(12):e0189840. PubMed ID: 29261752
[TBL] [Abstract][Full Text] [Related]
14. Circulating Calprotectin (cCLP) in autoimmune diseases.
Manfredi M; Van Hoovels L; Benucci M; De Luca R; Coccia C; Bernardini P; Russo E; Amedei A; Guiducci S; Grossi V; Bossuyt X; Perricone C; Infantino M
Autoimmun Rev; 2023 May; 22(5):103295. PubMed ID: 36781037
[TBL] [Abstract][Full Text] [Related]
15. Thoracic Involvement in Systemic Autoimmune Rheumatic Diseases: Pathogenesis and Management.
De Zorzi E; Spagnolo P; Cocconcelli E; Balestro E; Iaccarino L; Gatto M; Benvenuti F; Bernardinello N; Doria A; Maher TM; Zanatta E
Clin Rev Allergy Immunol; 2022 Dec; 63(3):472-489. PubMed ID: 35303257
[TBL] [Abstract][Full Text] [Related]
16. Coronary microvascular dysfunction pathophysiology in COVID-19.
Yin J; Wang S; Liu Y; Chen J; Li D; Xu T
Microcirculation; 2021 Oct; 28(7):e12718. PubMed ID: 34013612
[TBL] [Abstract][Full Text] [Related]
17. Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target?
Manolis AS; Tzioufas AG
Curr Vasc Pharmacol; 2020; 18(5):425-430. PubMed ID: 32410564
[TBL] [Abstract][Full Text] [Related]
18. Vasculitis associated with primary rheumatologic diseases.
Danning CL; Illei GG; Boumpas DT
Curr Opin Rheumatol; 1998 Jan; 10(1):58-65. PubMed ID: 9448991
[TBL] [Abstract][Full Text] [Related]
19. The altered metabolism profile in pathogenesis of idiopathic inflammatory myopathies.
Liu D; Zuo X; Luo H; Zhu H
Semin Arthritis Rheum; 2020 Aug; 50(4):627-635. PubMed ID: 32502727
[TBL] [Abstract][Full Text] [Related]
20. Accelerated atherogenesis in autoimmune rheumatic diseases.
Bacon PA; Stevens RJ; Carruthers DM; Young SP; Kitas GD
Autoimmun Rev; 2002 Dec; 1(6):338-47. PubMed ID: 12848989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
